Skip Main Navigation
Page Content
This event has ended

Xconomy Forum: Boston Biotech Seizes the Momentum

Xconomy

Thursday, April 4, 2013 at 1:30 PM (EDT)

Cambridge, MA

Xconomy Forum: Boston Biotech Seizes the Momentum

Ticket Information

Ticket Type Sales End Price Fee Quantity
Regular Registration Ended $325.00 $0.00
At the Door Ended $375.00 $0.00

Share Xconomy Forum: Boston Biotech Seizes the Momentum

Event Details

Xconomy Forum: Boston Biotech Seizes the Momentum

Something special is happening in Boston biotech. While many regions struggle to fulfill their biotech dreams, Boston has seized momentum that could make it the world's No. 1 life sciences cluster for a generation. The mix of great research institutions, small biotech companies, Big Pharma, and medical centers of excellence appears to be taking on a life of its own, attracting more and more life sciences energy to Boston. What has gone right? What's still missing? What needs to happen next for Boston to make the most of this opportunity? Join Xconomy for a series of in-depth conversations with leading CEOs, venture capitalists, and scientific entrepreneurs who are creating the biotech future in Boston.

Keynote and Featured speakers:
Bob Langer, David H. Koch Institute Professor, MIT
Christoph Westphal
, CEO, Verastem
Mara Aspinall, CEO, Roche/Ventana Medical Systems
Bruce Booth
, Managing Director, Atlas Venture
Deborah Dunsire, CEO, Millennium: Takeda
Jeff Leiden, CEO, Vertex Pharmaceuticals
Mike Pellini, CEO, Foundation Medicine
Alfred Sandrock, Chief Medical Officer, Biogen Idec
David Schenkein, CEO, Agios Pharmaceuticals
Bob Tepper, Partner, Third Rock Ventures
Luke Timmerman, National Biotechnology Editor, Xconomy

Schedule:
Registration: 12:30 – 1:30 pm
Program: 
1:30 – 5:30 pm
Networking Reception: 5:30
– 6:30 pm

Full agenda here

Twitter:
@Xconomy
#xconBio

Registration information:
Tickets are transferable but not refundable.
To inquire about press registration, e-mail events@xconomy.com.


EVENT HOST

Biogen Idec

EVENT SPONSORS

Alexandria Real Estate Equities; Comcast Business; Cubist Pharmaceuticals; Guard Dog Brand Development; Halloran Consulting Group; MFA-Moody, Famiglietti & Andronico; Nutter McClennen & Fish

 

EVENT PARTNER

MassBio


NATIONAL PARTNER
Alexandra Real Estate Equities

CHARTER UNDERWRITERS
Biogen Idec
WilmerHale

UNDERWRITERS
Comcast • Cubist Pharmaceuticals • 
Guard Dog Brand Development • Halloran Consulting Group
IDA Ireland • Kauffman Foundation • Kilpatrick Townsend • Latham & Watkins LLP
MFA-Moody Famiglietti & Andronico • Rice University • SRI International Texas Medical Center • Turnstone

VENTURE CAPITAL MEMBERS
Advanced Technology Ventures • 
ARCH Venture Partners • Avalon Ventures
Boston Millennia Partners • Fairhaven Capital • Flagship Ventures • General Catalyst
North Bridge Venture Partners • Polaris Venture Partners • SR One • Third Rock Ventures

Have questions about Xconomy Forum: Boston Biotech Seizes the Momentum? Contact Xconomy

When & Where


Biogen Idec - Building 8
14-15 Cambridge Center
Cambridge, MA 02142

Thursday, April 4, 2013 at 1:30 PM (EDT)


  Add to my calendar

Organizer

Xconomy

Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at www.xconomy.com/about.

Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at http://www.xconomy.com/rss-feeds/.

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.